切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2026, Vol. 12 ›› Issue (03) : 301 -307. doi: 10.3877/cma.j.issn.2096-1537.2026.03.011

综述

体外二氧化碳清除技术在急性呼吸窘迫综合征患者中的应用进展
潘陈伟, 李晓青†(), 马璐, 陈管洁, 钱淑媛   
  1. 210009 南京,东南大学附属中大医院重症医学科
  • 收稿日期:2024-11-09 出版日期:2026-08-28
  • 通信作者: 李晓青

Progress of application of extracorporeal carbon dioxide removal in patients with acute respiratory distress syndrome

Chenwei Pan, Xiaoqing Li†(), Lu Ma, Guanjie Chen, Shuyuan Qian   

  1. Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China
  • Received:2024-11-09 Published:2026-08-28
  • Corresponding author: Xiaoqing Li
引用本文:

潘陈伟, 李晓青, 马璐, 陈管洁, 钱淑媛. 体外二氧化碳清除技术在急性呼吸窘迫综合征患者中的应用进展[J/OL]. 中华重症医学电子杂志, 2026, 12(03): 301-307.

Chenwei Pan, Xiaoqing Li, Lu Ma, Guanjie Chen, Shuyuan Qian. Progress of application of extracorporeal carbon dioxide removal in patients with acute respiratory distress syndrome[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2026, 12(03): 301-307.

体外二氧化碳清除技术(ECCO2R)是一种低血流量的体外生命支持技术,可以清除急性呼吸窘迫综合征(ARDS)患者血液中过量的二氧化碳,从而纠正高碳酸血症和呼吸性酸中毒,促进肺保护通气的实施。但由于缺乏明确的指南和规范,在临床实践中ARDS患者应用本项技术存在较大差异。本文介绍了ECCO2R的运行模式、适应证、禁忌证,在ARDS患者中的启动与终止时机、实施中的监测、并发症处理,以及对该类患者应用此项技术过程中的护理难点进行总结并提出建议,以期为该类患者ECCO2R的护理实践提供参考。

Extracorporeal carbon dioxide removal is a low-flow extracorporeal life support technique that removes excess carbon dioxide from the blood of patients with acute respiratory distress syndrome, thereby correcting hypercapnia and respiratory acidosis and facilitating the implementation of lung protective ventilation. However, due to the lack of clear guidelines and protocols, the clinical application of this technique in patients with acute respiratory distress syndrome varies considerably. This article introduces the operational mode, indications, and contraindications of extracorporeal carbon dioxide removal, as well as the timing of initiation and termination, monitoring during implementation, and management of complications in patients with acute respiratory distress syndrome. It also summarizes the nursing challenges associated with the application of this technique and offers recommendations, aiming to provide a reference for nursing practice and improve clinical outcomes in this patient population.

图1 ECCO2R治疗流程 注:ARDS为急性呼吸窘迫综合征;PaCO2为动脉血二氧化碳分压;RR为呼吸频率;ECCO2R为体外二氧化碳清除技术;APTT为活化部分凝血活酶时间;ACT为活化凝血时间;P/F为氧合指数;ECMO为体外膜氧合
图2 OMNI血滤机联合ECCO2R标准操作流程 注:ECCO2R为体外二氧化碳清除技术
1
Matthay MA, Arabi Y, Arroliga AC, et al. A new global definition of acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2024, 209(1): 37-47.
2
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries[J]. JAMA, 2016, 315(8): 788-800.
3
Banavasi H, Nguyen P, Osman H, et al. Management of ARDS - what works and what does not[J]. Am J Med Sci, 2021, 362(1): 13-23.
4
Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome[J]. N Engl J Med, 2000, 342(18): 1301-1308.
5
Gattinoni L, Kolobow T, Tomlinson T, et al. Low-frequency positive pressure ventilation with extracorporeal carbon dioxide removal (LFPPV-ECCO2R): an experimental study[J]. Anesth Analg, 1978, 57(4): 470-477.
6
Terragni PP, Del Sorbo L, Mascia L, et al. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal[J]. Anesthesiology, 2009, 111(4): 826-835.
7
Combes A, Fanelli V, Pham T, et al. Feasibility and safety of extracorporeal CO2 removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study[J]. Intensive Care Med, 2019, 45(5): 592-600.
8
Cove ME, MacLaren G, Federspiel WJ, et al. Bench to bedside review: extracorporeal carbon dioxide removal, past present and future[J]. Crit Care, 2012, 16(5): 232.
9
Karagiannidis C, Philipp A, Strassmann S, et al. Extracorporeal CO2 elimination (ECCO2R) for hypercapnic respiratory failure: from pathophysiology to clinical application[J]. Pneumologie, 2017, 71(4): 215-220.
10
Camporota L, Barrett N. Current applications for the use of extracorporeal carbon dioxide removal in critically ill patients[J]. Biomed Res Int, 2016, 2016: 9781695.
11
Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study[J]. JAMA, 2005, 294(7): 813-818.
12
Consales G, Zamidei L, Turani F, et al. Combined renal-pulmonary extracorporeal support with low blood flow techniques: a retrospective observational study (CICERO Study)[J]. Blood Purif, 2022, 51(4): 299-308.
13
张友福, 王芳, 张凌, 等. 连续性肾脏替代治疗串联体外二氧化碳清除技术治疗呼吸衰竭合并急性呼吸窘迫综合征一例[J]. 华西医学, 2022, 37(7): 1115-1117.
14
De Bels D, Pierrakos C, Spapen HD, et al. A double catheter approach for extracorporeal CO2 removal integrated within a continuous renal replacement circuit[J]. J Transl Int Med, 2018, 6(4): 157-158.
15
Combes A, Auzinger G, Capellier G, et al. ECCO2R therapy in the ICU: consensus of a European round table meeting[J]. Crit Care, 2020, 24(1): 490.
16
Ekechukwu N, Batra S, Orsi D, et al. Outcomes of extracorporeal life support (ECLS) in acute severe asthma: a narrative review[J]. Lung, 2024, 202(2): 91-96.
17
Wiebe K, Poeling J, Arlt M, et al. Thoracic surgical procedures supported by a pumpless interventional lung assist[J]. Ann Thorac Surg, 2010, 89(6): 1782-1787; discussion 1788.
18
Schellongowski P, Riss K, Staudinger T, et al. Extracorporeal CO2 removal as bridge to lung transplantation in life-threatening hypercapnia[J]. Transpl Int, 2015, 28(3): 297-304.
19
Combes A, Brodie D, Aissaoui N, et al. Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions[J]. Intensive Care Med, 2022, 48(10): 1308-1321.
20
Combes A, Auzinger G, Camporota L, et al. Expert perspectives on ECCO2R for acute hypoxemic respiratory failure: consensus of a 2022 European roundtable meeting[J]. Ann Intensive Care, 2024, 14(1): 132.
21
潘陈伟, 王文春, 陈管洁, 等. 5例重度急性呼吸窘迫综合征合并高碳酸血症患者行体外二氧化碳清除治疗的护理[J]. 中华护理杂志, 2024, 59(2): 214-218.
22
Almanza-Hurtado A, Polanco Guerra C, Martínez-Ávila MC, et al. Hypercapnia from physiology to practice[J]. Int J Clin Pract, 2022, 2022: 2635616.
23
Pisani L, Corcione N, Nava S. Management of acute hypercapnic respiratory failure[J]. Curr Opin Crit Care, 2016, 22(1): 45-52.
24
王章武, 肖东. 呼气末二氧化碳分压监测在急性呼吸窘迫综合征中的应用[J]. 临床合理用药杂志, 2021, 14(1): 163-164.
25
Goligher EC, Amato M, Slutsky AS. Applying precision medicine to trial design using physiology. Extracorporeal CO2 removal for acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2017, 196(5): 558-568.
26
Wearden PD, Federspiel WJ, Morley SW, et al. Respiratory dialysis with an active-mixing extracorporeal carbon dioxide removal system in a chronic sheep study[J]. Intensive Care Med, 2012, 38(10): 1705-1711.
27
Karagiannidis C, Kampe KA, Sipmann FS, et al. Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations[J]. Crit Care, 2014, 18(3): R124.
28
Tiruvoipati R, Akkanti B, Dinh K, et al. Extracorporeal carbon dioxide removal with the Hemolung in patients with acute respiratory failure: a multicenter retrospective cohort study[J]. Crit Care Med, 2023, 51(7): 892-902.
29
McMichael A, Ryerson LM, Ratano D, et al. 2021 ELSO adult and pediatric anticoagulation guidelines[J]. ASAIO J, 2022, 68(3): 303-310.
30
Tiruvoipati R, Ludski J, Gupta S, et al. Evaluation of the safety and efficacy of extracorporeal carbon dioxide removal in the critically ill using the PrismaLung+ device[J]. Eur J Med Res, 2023, 28(1): 291.
31
Braune S, Sieweke A, Jarczak D, et al. Extracorporeal lung support[J]. Med Klin Intensivmed Notfmed, 2017, 112(5): 426-436.
32
Fitzgerald M, Millar J, Blackwood B, et al. Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review[J]. Crit Care, 2014, 18(3): 222.
33
Sklar MC, Beloncle F, Katsios CM, et al. Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review[J]. Intensive Care Med, 2015, 41(10): 1752-1762.
34
陈廷芳, 盛晓华, 张海英, 等. 体外二氧化碳清除联合连续性肾脏替代治疗救治尿毒症合并新型冠状病毒感染重症患者1例[J]. 中华内科杂志, 2024, 63(9): 889-892.
35
Sharma AS, Weerwind PW, Bekers O, et al. Carbon dioxide dialysis in a swine model utilizing systemic and regional anticoagulation[J]. Intensive Care Med Exp, 2016, 4(1): 2.
36
Cavayas YA, Munshi L, Del Sorbo L, et al. The early change in PaCO2 after extracorporeal membrane oxygenation initiation is associated with neurological complications[J]. Am J Respir Crit Care Med, 2020, 201(12): 1525-1535.
37
Schmidt M, Jaber S, Zogheib E, et al. Feasibility and safety of low-flow extracorporeal CO2 removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS[J]. Crit Care, 2018, 22(1): 122.
38
Park M, Costa EL, Maciel AT, et al. Determinants of oxygen and carbon dioxide transfer during extracorporeal membrane oxygenation in an experimental model of multiple organ dysfunction syndrome[J]. PLoS One, 2013, 8(1): e54954.
39
Karagiannidis C, Strassmann S, Brodie D, et al. Impact of membrane lung surface area and blood flow on extracorporeal CO2 removal during severe respiratory acidosis[J]. Intensive Care Med Exp, 2017, 5(1): 34.
40
Qian Z, He H, Wang Y, et al. Evaluation of CO2 removal rate of ECCO2R for a renal replacement therapy platform in an experimental setting[J]. Artif Organs, 2024, 48(6): 586-594.
41
Ding X, Chen H, Zhao H, et al. ECCO2R in 12 COVID-19 ARDS patients with extremely low compliance and refractory hypercapnia[J]. Front Med (Lausanne), 2021, 8: 654658.
42
Allardet-Servent J, Castanier M, Signouret T, et al. Safety and efficacy of combined extracorporeal CO2 removal and renal replacement therapy in patients with acute respiratory distress syndrome and acute kidney injury: the pulmonary and renal support in acute respiratory distress syndrome study[J]. Crit Care Med, 2015, 43(12): 2570-2581.
43
Gattinoni L. Ultra-protective ventilation and hypoxemia[J]. Crit Care, 2016, 20(1): 130.
44
McNamee JJ, Gillies MA, Barrett NA, et al. Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: the REST randomized clinical trial[J]. JAMA, 2021, 326(11): 1013-1023.
45
Cambria G, Spelde AE, Olia SE, et al. Extracorporeal carbon dioxide removal to de-escalate venovenous extracorporeal membrane oxygenation in severe COVID-19 acute respiratory distress syndrome[J]. J Cardiothorac Vasc Anesth, 2024, 38(3): 717-723.
46
Cavayas YA, Thakore A, Fan E. Extracorporeal strategies in acute respiratory distress syndrome[J]. Semin Respir Crit Care Med, 2019, 40(1): 114-128.
47
Fan Z, Zhu S, Chen J, et al. The application of extracorporeal membrane oxygenation in emergent airway management - a single-center retrospective study[J]. J Cardiothorac Surg, 2024, 19(1): 20.
48
Montanaro J. Using in situ simulation to develop a prone positioning protocol for patients with ARDS[J]. Crit Care Nurse, 2020: e1-e13.
[1] 陈静, 曲东, 刘霜. 急性呼吸窘迫综合征细胞治疗机制及临床应用研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(06): 327-334.
[2] 张阿妮, 王冠华, 袁亚迎, 任志超, 梁杰, 赵蕊新, 陈妍, 郭娟妮, 康瑞. 肺超声联合膈肌超声检测指标预测急性呼吸窘迫综合征患者拔管的临床研究—附126例分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(03): 392-398.
[3] 甘志新, 胡雍军, 杨倩, 胡明冬. 75例急性呼吸窘迫综合征的临床特征及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(02): 221-226.
[4] 梅春霞, 冯霞, 邬海桥, 刘攀, 李昆霖, 徐智, 刘禹. 肺损伤预测评分联合血管生成素-2对肺部感染并发急性呼吸窘迫综合征的预测意义[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 9-14.
[5] 吴蓉, 蔡喆燚, 黄运华, 乐金海, 张萍, 陈献, 易琼. 跨肺驱动压导向呼气末正压通气对急性呼吸窘迫综合征患者肺功能及预后的影响[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 866-871.
[6] 沈方龙, 伍正彬, 邵世锋, 陈地友, 肖钦, 郝志鹏, 王震, 赵辉, 王耀丽. 急性呼吸窘迫综合征患者的生物电阻抗断层成像特征及预测研究[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 897-903.
[7] 刘雅文, 孙延虎, 许晓函, 李岳, 王旭东. 电阻抗断层成像技术指导滴定呼气末正压通气治疗急性呼吸窘迫综合征患者的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 966-972.
[8] 黎佩雯, 方年新, 游俊廷, 赖辉燕. 血红蛋白与红细胞分布宽度比值在危重ARDS患者肾脏替代治疗中的L形关联[J/OL]. 中华重症医学电子杂志, 2026, 12(03): 279-289.
[9] 史楠, 袁雪燕, 刘玲, 邱海波. 急性呼吸窘迫综合征表型及药物治疗的研究进展[J/OL]. 中华重症医学电子杂志, 2026, 12(03): 267-271.
[10] 娄熙冉, 袁雪燕, 邱海波, 刘玲. 急性呼吸窘迫综合征机械通气的研究进展[J/OL]. 中华重症医学电子杂志, 2026, 12(03): 262-266.
[11] 伍宵, 唐颖, 张曦文, 邱海波. 表观遗传修饰调控急性呼吸窘迫综合征发病机制的研究进展[J/OL]. 中华重症医学电子杂志, 2026, 12(02): 202-207.
[12] 张莉, 谢剑锋, 张学超, 王静, 王伟, 钱淑媛. 重度急性呼吸窘迫综合征患者客观评估导向的精准化镇痛镇静一例[J/OL]. 中华重症医学电子杂志, 2026, 12(02): 214-218.
[13] 于丽娜, 张晓丽, 胡继宽, 张广稳, 钱会涛, 丁喜珍, 张颖, 陈齐红. 西维来司他钠调节Th17/Treg平衡改善多发伤相关ARDS患者氧合的随机对照研究[J/OL]. 中华临床医师杂志(电子版), 2025, 19(12): 919-925.
[14] 彭坤, 冯辉斌, 袁利学. 急性有机磷农药中毒并发急性呼吸窘迫综合征的危险因素相关性[J/OL]. 中华临床医师杂志(电子版), 2025, 19(09): 668-674.
[15] 张立, 李巧妮, 贺帅, 王朝霞, 宁小康. 连续性血液净化联合血液灌流在严重脓毒症合并急性呼吸窘迫综合征患者中的应用效果及PCT、hs-CRP、IL-6水平影响[J/OL]. 中华卫生应急电子杂志, 2026, 12(01): 26-31.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?